But first-line medication—including ropinirole (Requip) and pramipexole (Mirapex), which the Food and Drug Administration approved for the treatment of RLS—are sometimes unsuccessful because ...
Background Ropinirole prolonged release (RPR) is a once-daily formulation. However, there may be individual pharmacokinetic differences so that multiple dosing may be preferred in some individuals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback